Clinical utilization of four-factor prothrombin complex concentrate: a retrospective single center study
Objective Four-factor prothrombin complex concentrate (4F-PCC) was approved by the US Food and Drug Administration in 2013 for management of severely bleeding patients on warfarin therapy. We describe use of 4F-PCC at a large, suburban academic center. Methods We retrospectively reviewed all patient...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
The Korean Society of Emergency Medicine
2021-06-01
|
Series: | Clinical and Experimental Emergency Medicine |
Subjects: | |
Online Access: | http://ceemjournal.org/upload/pdf/ceem-20-017.pdf |